Intervention with immunomodulatory agents: monoclonal antibody therapy

Abramowicz, 1989, Release of tumor necrosis factor, interleukin-2 and interferon-gamma in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients, Transplantation, 47, 606, 10.1097/00007890-198904000-00008 Becker, 1990, Imaging autoimmune rheumatoid arthritis specifically with technetium-99m CD4-specific (T-helper lymphocytes) antibodies, European Journal of Nuclear Medicine, 17, 156, 10.1007/BF00811445 Benjamin, 1988, Mechanism of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA1) molecules in self-non-self discrimination, European Journal of Immunology, 18, 1079, 10.1002/eji.1830180717 Burmester, 1991, Hit and run or permanent hit?—Is there evidence for a microbiological cause of rheumatoid arthritis?, Journal of Rheumatology, 18, 1442 Burmester, 1989, Monocytes in rheumatoid arthritis, 501 Burmester, 1981, Characterization of Ia+T cells in patients with rheumatoid arthritis, Arthritis and Rheumatism, 24, 1370, 10.1002/art.1780241106 Burmester, 1984, Activated T cells in vivo and in vitro: Different phenotypic expression of Tac and Ia antigens in patients with inflammatory joint diseases and normal in vitro activated T cells, Journal of Immunology, 133, 1230, 10.4049/jimmunol.133.3.1230 Burmester, 1992, Cellular and humoral immune response against articular chondrocytes and proteoglycans in rheumatoid arthritis Cannon, 1991, Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate, Arthritis and Rheumatism, 34, S157 Cobbold, 1984, Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo, Nature, 312, 548, 10.1038/312548a0 Conolly, 1990, A small subset of CD4+ T cells is sufficient to promote autoimmune disease in lupus-prone NZB/NZW mice, Arthritis and Rheumatism, 33, S23-s2 Courtney-Luck, 1986, Development of primary and secondary immune response to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasm, Cancer Research, 46, 6489 Cush, 1991, Treatment of rheumatoid arthritis with an anti-CD5 immunoconjugate, Arthritis and Rheumatism, 34, S159 Didri, 1991, Treatment of rheumatoid arthritis with monoclonal anti-CD4 antibodies. Clinical results, Arthritis and Rheumatism, 34, S92 Firestein, 1988, Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophagecolony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis, Journal of Experimental Medicine, 168, 1573, 10.1084/jem.168.5.1573 Fishwild, 1991, Analysis of immune function and phenotype in RA patients treated with an anti-CD5 immunoconjugate, Arthritis and Rheumatism, 34, S125 Goldstein, 1986, OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3, Transplantation, 42, 507, 10.1097/00007890-198611000-00013 Goronzy, 1986, Long-term humoral unresponsiveness in vivo induced by treatment with monoclonal antibody against L3T4, Journal of Experimental Medicine, 164, 911, 10.1084/jem.164.3.911 Hafler, 1988, Immunosuppression with monoclonal antibodies in multiple sclerosis, Neurology, 38, 42 Hafler, 1988, Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis, Journal of Immunology, 141, 131, 10.4049/jimmunol.141.1.131 Hain, 1991, Stimulation of rheumatoid synovial and blood T cell clones and lines by synovial fluid and interleukin-2. Characterization of clones and recognition of a co-stimulatory effect, Rheumatology International, 10, 203, 10.1007/BF02274834 Hemler, 1986, Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation, Journal of Clinical Investigation, 78, 696, 10.1172/JCI112629 Herbert, 1988, Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants, Transplantation, 46, 128S, 10.1097/00007890-198808001-00024 Herzog, 1987, Monoclonal anti-CD4 in arthritis, Lancet, ii, 1461, 10.1016/S0140-6736(87)91158-5 Herzog, 1989, Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells, Journal of Autoimmunity, 2, 627, 10.1016/S0896-8411(89)80002-2 Holoshitz, 1983, Lines of lymphocytes induce or vaccinate against autoimmune arthritis, Science, 219, 56, 10.1126/science.6336851 Horneff, 1991, Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody, Arthritis and Rheumatism, 34, 129, 10.1002/art.1780340202 Horneff, 1991, Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis, Clinical Immunology and Immunopathology, 59, 89, 10.1016/0090-1229(91)90084-N Horneff, 1991, Human anti-mouse immunoglobulin antibodies confounding the determination of TSH, Klinische Wochenschrift, 69, 220, 10.1007/BF01646945 Horneff, 1991, Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma and interleukin-2 in systemic reactions induced by anti-CD4 therapy inpatients with rheumatoid arthritis, Cytokine, 3, 1, 10.1016/1043-4666(91)90026-A Horneff, 1992, Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 ratio induced by anti-CD4 therapy, Journal of Rheumatology Jaffers, 1986, Monoclonal antibody therapy: Antiidiotypic and non antiidiotypic antibodies to OKT3 arise despite intense immunosuppression, Transplantation, 41, 572, 10.1097/00007890-198605000-00004 Jahn, 1987, Functional and phenotypical characterization of activated T cells in inflammatory joint diseases. Possible modulation of the CD3 antigen, Scandinavian Journal of Immunology, 26, 745, 10.1111/j.1365-3083.1987.tb02312.x Jonker, 1987, Idiotype switching of CD4-specific monoclonal antibodies can prolong the therapeutic effectiveness in spite of host anti-mouse IgG antibodies, European Journal of Immunology, 17, 1547, 10.1002/eji.1830171104 Jonker, 1987, Effects of CD4 and CD8 specific monoclonal antibodies in vitro and in vivo on T cells and their relation to the allograft response in rhesus monkeys, Transplantation Proceedings, XIX, 4308 Karsh, 1981, Lymphapheresis in rheumatoid arthritis, Arthritis and Rheumatism, 24, 867, 10.1002/art.1780240701 Kerr, 1989, The effects of OKT3 therapy on infiltrating lymphocytes in rejecting renal allografts, Transplantation, 48, 33, 10.1097/00007890-198907000-00008 Kirkham, 1991, Monoclonal antibody therapy in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody, British Journal of Rheumatology, 10.1093/rheumatology/30.6.459 1989 Kotzin, 1981, Treatment of intractable rheumatoid arthritis with total lymphoid irradiation, New England Journal of Medicine, 305, 969, 10.1056/NEJM198110223051702 Kyle, 1989, Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis, Annals of the Rheumatic Diseases, 48, 428, 10.1136/ard.48.5.428 Möbius, 1989, Cluster Report CD4, 314 Moreland, 1991, Use of a chimeric anti-CD4 monoclonal antibody in refractory rheumatoid arthritis, Arthritis and Rheumatism, 34, S49 Nüsslein, 1985, Total lymphoid irradiation in patients with refractory rheumatoid arthritis, Arthritis and Rheumatism, 28, 1205, 10.1002/art.1780281103 Olsen, 1991, In vivo T cell depletion in rheumatoid arthritis is associated with increased IgM-rheumatoid factor synthesis, Arthritis and Rheumatism, 34, S125 Ortho Multicenter Transplant Study Group, 1985, A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants, New England Journal of Medicine, 313, 337, 10.1056/NEJM198508083130601 Paulus, 1977, Lymphocyte involvement in rheumatoid arthritis: studies during thoracic duct drainage, Arthritis and Rheumatism, 20, 1249, 10.1002/art.1780200614 Potocnik, 1991, Expression of the CD2 activation epitope T11-3 (CD2R) on T cells in rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, andLyme disease: phenotypic and functional analysis, Scandinavian Journal of Immunology, 34, 351, 10.1111/j.1365-3083.1991.tb01556.x Reiter, 1991, Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacological effects in an open study, includingrepeated administration, Arthritis and Rheumatism, 34, 525, 10.1002/art.1780340504 Reiter, 1991, Chimeric monoclonal CD4 antibody cM-T412 induces a long lasting CD4 cell depletion in rheumatoid arthritis (RA) patients, Arthritis and Rheumatism, 34, S91 Rose, 1987, In vivo administration of anti-CD4 monoclonal antibody prolongs survival in longtailed macaques with experimental encephalomyelitis, Clinical Immunology and Immunopathology, 45, 405, 10.1016/0090-1229(87)90093-6 Schroff, 1985, Human anti-murine immunoglobulin response in patients receiving monoclonal antibody therapy, Cancer Research, 45, 879 Strand, 1990, Treatment of rheumatoid arthritis with an anti-CD5 immunoconjugate: clinical and immunologic findings and preliminary results of re-treatment, Arthritis and Rheumatism, 33, S25-s2 Strand, 1991, Treatment of rheumatoid arthritis with an anti-CD5 immunoconjugate: final results of phase II studies, Arthritis and Rheumatism, 34, S91 Swinnen, 1990, Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients, New England Journal of Medicine, 323, 1723, 10.1056/NEJM199012203232502 Trentham, 1981, Clinical and immunological effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis, New England Journal of Medicine, 305, 976, 10.1056/NEJM198110223051703 Van der Lubbe, 1991, Treatment of rheumatoid arthritis (RA) with chimeric CD4 monoclonal antibody, Arthritis and Rheumatism, 34, S89 Wacholtz, 1991, Treatment of lupus nephritis with CD5 Plus, an immunoconjugate of anti-CD5 monoclonal antibody and ricin A chain, Arthritis and Rheumatism, 34, S58 Wendling, 1991, Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis, Journal of Rheumatology, 18, 325 Wilder, 1983, T-inducer lymphocytes, leukapheresis and the pathogenesis of rheumatoid arthritis, Clinical and Experimental Rheumatology, 1, 89 Winter, 1991, Man-made antibodies, Nature, 349, 293, 10.1038/349293a0